Literature DB >> 15334250

The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis.

Roberta O Pinheiro1, Eduardo F Pinto, Alessandra B Benedito, Ulisses G Lopes, Bartira Rossi-Bergmann.   

Abstract

Leishmania amazonensis is the main agent of diffuse cutaneous leishmaniasis, a disease associated with anergic immune responses. In this study we show that the crude antigen of Leishmania amazonensis (LaAg) but not L. braziliensis promastigotes (LbAg) contains substances that suppress mitogenic and spontaneous proliferative responses of T cells. The suppressive substances in LaAg are thermoresistant (100 degrees C/1h) and partially dependent on protease activity. T cell anergy was not due to a decreased production of growth factors as it was not reverted by addition of exogenous IL-2, IL-4, IFN-gamma or IL-12. LaAg did not inhibit anti-CD3-induced T cell activation, suggesting that anergy was due to a defect in antigen presentation. It was also not due to cell necrosis, but was accompanied by expressive DNA fragmentation in lymph node cells, indicative of apoptosis. Although pre-incubation of macrophages with LaAg prevented their capacity to present antigens, this effect was not due to apoptosis of the former. These results suggest that the T cell anergy found in diffuse leishmaniasis may be the result of parasite antigen-driven apoptosis of those cells following defective antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334250     DOI: 10.1590/s0001-37652004000300006

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  12 in total

1.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.

Authors:  E Telino; P M De Luca; D C S Matos; R B Azeredo-Coutinho; M N Meirelles; F Conceição-Silva; A Schubach; S C F Mendonça
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease/esterase activity, and parasite and host genetic backgrounds.

Authors:  Virgínia M G Silva; Daniela F Larangeira; Pablo R S Oliveira; Romina B Sampaio; Paula Suzart; Jorge S Nihei; Márcia C A Teixeira; José O Mengel; Washington L C dos-Santos; Lain Pontes-de-Carvalho
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

Review 4.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Revisiting the Principles of Designing a Vaccine.

Authors:  Shubhranshu Zutshi; Sunil Kumar; Prashant Chauhan; Bhaskar Saha
Journal:  Methods Mol Biol       Date:  2022

6.  Induction of Oxidative Stress in Skin and Lung of Infected BALB/C Mice with Iranian Strain of Leishmania major (MRHO/IR/75/ER).

Authors:  Mahvash Jafari; Shanaz Shirbazou; Majid Norozi
Journal:  Iran J Parasitol       Date:  2014-03       Impact factor: 1.012

7.  The role of apoptosis in the cellular response of liver and spleen of BALB/c mice in cutaneous leishmaniasis.

Authors:  Mahvash Jafari; Shanaz Shirbazou; Seyed Homayoon Sadraie; Gholamreza Kaka; Majid Norozi
Journal:  Iran J Med Sci       Date:  2015-03

8.  MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.

Authors:  Diogo Oliveira-Maciel; Júlio Souza Dos-Santos; Gabriel Oliveira-Silva; Mirian França de Mello; Alessandra Marcia da Fonseca-Martins; Monique Pacheco Duarte Carneiro; Tadeu Diniz Ramos; Luan Firmino-Cruz; Daniel Claudio Oliveira Gomes; Bartira Rossi-Bergmann; Herbert Leonel de Matos Guedes
Journal:  Microorganisms       Date:  2021-06-11

9.  Modulation of innate antigen-presenting cell function by pre-patent schistosome infection.

Authors:  Christine E Ferragine; Colleen D Walls; Stephen J Davies
Journal:  PLoS Negl Trop Dis       Date:  2013-03-21

10.  Subversion and Utilization of Host Innate Defense by Leishmania amazonensis.

Authors:  Lynn Soong
Journal:  Front Immunol       Date:  2012-03-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.